Development of Novel Acoustic Clusters for Improving Combinatorial Neuroblastoma Therapy
开发新型声学簇以改善神经母细胞瘤组合治疗
基本信息
- 批准号:10738338
- 负责人:
- 金额:$ 4.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-03-12 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:3D ultrasoundAbdomenAchievementAcousticsAcuteAddressAdrenal GlandsAgeAntibodiesArchitectureAreaBirthBlood VesselsCancer ModelCephalicChemicalsChildChild CareChildhoodClinicalContrast MediaDataDevelopmentDiameterDisease-Free SurvivalDoxorubicinDrug Delivery SystemsDrug TargetingDrug usageEncapsulatedExcisionFeedbackFluorocarbonsFocused UltrasoundGasesGoalsIncidenceKidneyKineticsLiposomal DoxorubicinLiposomesLong-Term EffectsMalignant Childhood NeoplasmMalignant NeoplasmsMeasuresMediatingMethodsMicrobubblesModelingMonitorMusNeuroblastomaOperative Surgical ProceduresOrgan SpecificityPatientsPediatric NeoplasmPenetrationPerfusionPericytesPermeabilityPharmaceutical PreparationsPharmacotherapyPropertyRelapseResearchRiskSiteSolid NeoplasmStimulusTechniquesTechnologyTestingTherapeuticTimeToxicity due to chemotherapyTreatment EfficacyTumor TissueUltrasonographyVascular PermeabilitiesVascular remodelingaggressive therapybevacizumabcancer diagnosischemotherapyclinically relevantcombinatorialcontrast enhancedcrosslinkdelivery vehicledemographicsdesigndosageexpectationexperiencehigh riskhumanized monoclonal antibodiesimage guidedimage-guided drug deliveryimprovedin vivoinnovationinsightmortalitynanoDropletnovelnovel strategiesnovel therapeuticsparticleperfusion imagingside effectsonoporationsoundstandard of caretreatment responsetumortumor growthultrasounduptakevessel regressionvibration
项目摘要
Development of Novel Acoustic Clusters for Improving Combinatorial Neuroblastoma Therapy
Summary: The goal of this project is to develop superior image-guided methods of delivering
chemotherapeutics to neuroblastoma, which are aggressive solid tumors responsible for 15% of childhood
cancer related mortalities. Neuroblastoma most commonly arises in the adrenal gland and kidneys, but also
other areas of the abdomen. Unlike many tumors, neuroblastomas are poorly perfused, requiring high-dosage
chemotherapy, which can have deleterious short and long-term side effects in children. Currently, no clinical
methods exist to optimize drug uptake in neuroblastoma in vivo. Methods of improving drug delivery to tumors
are needed to improve therapy.
In this study, we propose an innovative image-guided combinatorial drug therapy approach to remodel the
tumor vasculature and treat neuroblastoma, using anti-VEGF antibody, bevacizumab (BV), in combination with
acoustically delivered liposomal doxorubicin (L-DOX). Neither BV therapy nor L-DOX are currently indicated for
neuroblastoma treatment, but together with sound-sensitive ultrasound contrast agents (UCA's) they have the
potential to dramatically improve neuroblastoma treatment efficacy. BV therapy was designed to induce
vascular regression, however we and others have demonstrated that repetitive BV therapy causes vascular
remodeling in NGP mouse tumor models by “cooption” of surrounding vessels and potentially making them
more amenable to drug uptake by reducing mature pericyte coverage thereby compromising vascular integrity.
In combination with BV therapy, we will test a novel platform for enhancing drug uptake in tumors utilizing
ultrasound sensitive particles, called “Acoustic Clusters” (ACs), to maximize payload of doxorubicin specifically
to tumor tissue. ACs are chemically crosslinked gas-filled spheres (“microbubbles”, ~1 μm diameter each) that
vibrate in an ultrasound field. AC's are assembled using drug carrying liposomes and are specifically designed
to solubilize liposome-encapsulated drugs on-demand during ultrasound stimulation. ACs can also
permeabilize blood vessels facilitating uptake of released drugs. We will test several novel image-guided drug
delivery strategies using microbubble (and nanodroplet) based ACs to “uncage” encapsulated doxorubicin
(with and without permeabilizing blood vessels) to maximize drug uptake in tumors. The strategy of
simultaneously releasing drugs and permeabilizing vasculature is a novel approach that will enable more
efficient drug targeting and eliminate the reliance on endogenous tumor vascular permeability for liposome
encapsulated drug carrying molecules, such as L-DOX. The techniques developed in this study would be
applicable to a wide range of drugs and cancers toward improving overall treatment efficacies.
开发用于改进组合神经母细胞瘤治疗的新型声学簇
摘要:该项目的目的是开发出色的图像引导的交付方法
神经母细胞瘤的化学治疗剂是侵略性实体瘤,造成15%的童年
癌症相关的死亡率。神经母细胞瘤最常见于肾上腺和肾脏,但也发生
腹部的其他区域。与许多肿瘤不同,神经母细胞瘤灌注不佳,需要高剂量
化学疗法,可能对儿童产生有害的短期和长期副作用。目前,没有临床
存在优化体内神经母细胞瘤药物摄取的方法。改善药物输送到肿瘤的方法
需要改善治疗。
在这项研究中,我们提出了一种创新的图像引导的组合药物治疗方法来重塑
使用抗VEGF抗体贝伐单抗(BV),肿瘤脉管系统和治疗神经母细胞瘤,结合
声学递送的脂质体阿霉素(L-Dox)。目前均未指示BV疗法和L-DOX
神经母细胞瘤治疗,但与声音敏感的超声对比剂(UCA)一起,它们具有
显着提高神经母细胞瘤治疗效率的潜力。 BV疗法旨在诱导
血管回归,但是我们和其他人已经证明重复的BV疗法会导致血管
通过周围容器的“库存”在NGP小鼠肿瘤模型中进行重塑,并有可能使它们
通过减少成熟的周细胞覆盖范围,从而损害了血管完整性,更适合药物吸收。
结合BV疗法,我们将测试一个新型平台,以增强使用肿瘤中的药物吸收
超声敏感颗粒,称为“声学簇”(ACS),以最大程度地提高阿霉素的有效载荷
到肿瘤组织。 AC是化学交联的气体填充球(“微泡”,每个直径约为1μm)
在超声场中振动。 AC使用携带脂质体组装,并专门设计
在超声刺激期间,可溶性脂质体封装的药物按需点播。 ACS也可以
透化血管促进释放药物的吸收。我们将测试几种新型图像引导的药物
使用微泡(和纳米光)的ACS进行交付策略,以封装了阿霉素
(有或没有透化血管),以最大程度地吸收肿瘤的药物摄取。策略
简单地释放药物和透化脉管系统是一种新颖的方法,可以使更多
有效的药物靶向并消除了对脂质体内源性肿瘤血管通透性的依赖
封装携带分子的药物,例如L-Dox。这项研究中开发的技术将是
适用于广泛的药物和癌症,可提高整体治疗效率。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Remote Loading: The Missing Piece for Achieving High Drug Payload and Rapid Release in Polymeric Microbubbles.
- DOI:10.3390/pharmaceutics15112550
- 发表时间:2023-10-28
- 期刊:
- 影响因子:5.4
- 作者:Rastegar G;Salman MM;Sirsi SR
- 通讯作者:Sirsi SR
Non-invasive molecularly-specific millimeter-resolution manipulation of brain circuits by ultrasound-mediated aggregation and uncaging of drug carriers.
- DOI:10.1038/s41467-020-18059-7
- 发表时间:2020-10-01
- 期刊:
- 影响因子:16.6
- 作者:Ozdas MS;Shah AS;Johnson PM;Patel N;Marks M;Yasar TB;Stalder U;Bigler L;von der Behrens W;Sirsi SR;Yanik MF
- 通讯作者:Yanik MF
Remote Loading of Gas Bubbles into Polylactic Acid Microcapsules Creates Acoustically Active Janus Particles.
- DOI:10.1021/acsapm.1c01562
- 发表时间:2022-02-11
- 期刊:
- 影响因子:5
- 作者:Honari A;Kapilavaih PS;Akter N;Sirsi SR
- 通讯作者:Sirsi SR
Improving Release of Liposome-Encapsulated Drugs with Focused Ultrasound and Vaporizable Droplet-Liposome Nanoclusters.
- DOI:10.3390/pharmaceutics13050609
- 发表时间:2021-04-22
- 期刊:
- 影响因子:5.4
- 作者:Honari A;Merillat DA;Bellary A;Ghaderi M;Sirsi SR
- 通讯作者:Sirsi SR
The Evolution and Recent Trends in Acoustic Targeting of Encapsulated Drugs to Solid Tumors: Strategies beyond Sonoporation.
- DOI:10.3390/pharmaceutics15061705
- 发表时间:2023-06-10
- 期刊:
- 影响因子:5.4
- 作者:Honari A;Sirsi SR
- 通讯作者:Sirsi SR
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sonia Lorena Hernandez其他文献
Sonia Lorena Hernandez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sonia Lorena Hernandez', 18)}}的其他基金
Development of Novel Acoustic Clusters for Improving Combinatorial Neuroblastoma Therapy
开发新型声学簇以改善神经母细胞瘤组合治疗
- 批准号:
9762494 - 财政年份:2019
- 资助金额:
$ 4.9万 - 项目类别:
Development of Novel Acoustic Clusters for Improving Combinatorial Neuroblastoma Therapy
开发新型声学簇以改善神经母细胞瘤组合治疗
- 批准号:
9891989 - 财政年份:2019
- 资助金额:
$ 4.9万 - 项目类别:
Development of Novel Acoustic Clusters for Improving Combinatorial Neuroblastoma Therapy
开发新型声学簇以改善神经母细胞瘤组合治疗
- 批准号:
10579202 - 财政年份:2019
- 资助金额:
$ 4.9万 - 项目类别:
Development of Novel Acoustic Clusters for Improving Combinatorial Neuroblastoma Therapy
开发新型声学簇以改善神经母细胞瘤组合治疗
- 批准号:
10341157 - 财政年份:2019
- 资助金额:
$ 4.9万 - 项目类别:
Development of Novel Acoustic Clusters for Improving Combinatorial Neuroblastoma Therapy
开发新型声学簇以改善神经母细胞瘤组合治疗
- 批准号:
10599708 - 财政年份:2019
- 资助金额:
$ 4.9万 - 项目类别:
相似国自然基金
腹腔巨噬细胞通过IL-16信号通路介导子宫内膜异位症慢性腹部疼痛
- 批准号:32371043
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
C/EBPZ调控鸡腹部脂肪组织形成的生物学功能和作用机制研究
- 批准号:32360825
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
面向小器官精准分割的腹部CT影像多器官分割技术研究
- 批准号:62303127
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ABCC2转运蛋白在克氏原螯虾腹部肌肉中抗汞积累特性研究
- 批准号:32302982
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
面向腹部创伤的超声辅助诊断关键技术研究
- 批准号:62371121
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Infusion device optimization by addressing root causes of the inflammatory response
通过解决炎症反应的根本原因来优化输注装置
- 批准号:
10443241 - 财政年份:2022
- 资助金额:
$ 4.9万 - 项目类别:
Countermeasures to cardiovascular impairment during circadian misalignment
昼夜节律失调期间心血管损害的对策
- 批准号:
10538251 - 财政年份:2022
- 资助金额:
$ 4.9万 - 项目类别:
Countermeasures to cardiovascular impairment during circadian misalignment
昼夜节律失调期间心血管损害的对策
- 批准号:
10802104 - 财政年份:2022
- 资助金额:
$ 4.9万 - 项目类别:
Infusion device optimization by addressing root causes of the inflammatory response
通过解决炎症反应的根本原因来优化输注装置
- 批准号:
10612439 - 财政年份:2022
- 资助金额:
$ 4.9万 - 项目类别:
Multifunctional VAD Technology for High-Risk Pediatric Patients
适用于高危儿科患者的多功能 VAD 技术
- 批准号:
10642279 - 财政年份:2020
- 资助金额:
$ 4.9万 - 项目类别: